Effectiveness of barbed repositioning pharyngoplasty for the treatment of obstructive sleep apnea (OSA): a prospective randomized trial.


Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 13 01 2019
accepted: 09 10 2019
revised: 07 10 2019
pubmed: 2 12 2019
medline: 11 6 2021
entrez: 2 12 2019
Statut: ppublish

Résumé

The aim of our randomized clinical trial is to produce stronger evidence supporting barbed repositioning pharyngoplasty (BRP) as a therapeutic option for the treatment of obstructive sleep apnea (OSA). The trial was a single-center prospective controlled trial with two parallel arms (group A: BRP; group B: observation) and randomization. Baseline and 6-month polygraphy evaluating the apnea hypopnea index (AHI), oxygen desaturation index (ODI), and lowest oxygen saturation (LOS) were performed. To test the differences among groups of Student's t test, the role of each factor (univariate analysis) and their independent effect (multivariate analysis) was explored using logistic regression model as appropriate. Linear regression was also conducted. A significant reduction of AHI, ODI, LOS, and Epworth Sleepiness Scale (ESS) values was recorded in the BRP group. BRP showed to be more effective than observation. Logistic regression showed that preoperative AHI is related significantly to postoperative AHI within the BRP group. A linear regression showed that higher baseline AHI predicts more significant postoperative absolute AHI reduction. BRP appears to be a promising technique and might be included within the surgical armamentarium of a sleep surgeon. Patients affected by severe OSA may benefit from this surgery with more significant reduction of AHI values.

Identifiants

pubmed: 31786746
doi: 10.1007/s11325-019-01956-7
pii: 10.1007/s11325-019-01956-7
doi:

Substances chimiques

Hypnotics and Sedatives 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

687-694

Auteurs

Claudio Vicini (C)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy.
Unit of Otolaryngology, University of Ferrara, Ferrara, Italy.

Giuseppe Meccariello (G)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy.

Filippo Montevecchi (F)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy.

Andrea De Vito (A)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy.

Sabrina Frassineti (S)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy.

Riccardo Gobbi (R)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy.

Stefano Pelucchi (S)

Unit of Otolaryngology, University of Ferrara, Ferrara, Italy.

Giannicola Iannella (G)

Unit of Otolaryngology, La Sapienza University, Rome, Italy.

Giuseppe Magliulo (G)

Unit of Otolaryngology, La Sapienza University, Rome, Italy.

Giovanni Cammaroto (G)

Unit of Otolaryngology, Hospital Morgagni Pierantoni, Forlì, Italy. giovanni.cammaroto@hotmail.com.
Unit of Otolaryngology, University of Messina, Messina, Italy. giovanni.cammaroto@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH